These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 27448185)
21. The International Society for Behavioral Medicine (ISBM) and the Society of Behavioral Medicine (SBM) advocate for the inclusion of behavioral scientists in the implementation of the Global Action Plan for the prevention of non-communicable diseases (NCDs) in low- and middle-income countries. Odukoya O; Fox RS; Hayman LL; Penedo FJ Transl Behav Med; 2021 Jun; 11(6):1286-1288. PubMed ID: 33410489 [TBL] [Abstract][Full Text] [Related]
22. Prospects for the Primary Prevention of Myocardial Infarction and Stroke. Caldwell M; Martinez L; Foster JG; Sherling D; Hennekens CH J Cardiovasc Pharmacol Ther; 2019 May; 24(3):207-214. PubMed ID: 30563358 [TBL] [Abstract][Full Text] [Related]
24. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. Avan A; Digaleh H; Di Napoli M; Stranges S; Behrouz R; Shojaeianbabaei G; Amiri A; Tabrizi R; Mokhber N; Spence JD; Azarpazhooh MR BMC Med; 2019 Oct; 17(1):191. PubMed ID: 31647003 [TBL] [Abstract][Full Text] [Related]
25. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017. Krishnamurthi RV; Ikeda T; Feigin VL Neuroepidemiology; 2020; 54(2):171-179. PubMed ID: 32079017 [TBL] [Abstract][Full Text] [Related]
26. Non-communicable Diseases Week: Best Practices in Addressing the NCDs Burden from Tanzania. Njiro BJ; Ngowi JE; Ndumwa HP; Amani D; Munishi C; Mloka D; Balandya E; Rugajo P; Kessy AT; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF; Mboya EA; Kikula AI; Kitambala E; Kiologwe J; Kengia JT; Kapologwe N Ann Glob Health; 2023; 89(1):89. PubMed ID: 38107601 [TBL] [Abstract][Full Text] [Related]
27. Strokes in young adults: epidemiology and prevention. Smajlović D Vasc Health Risk Manag; 2015; 11():157-64. PubMed ID: 25750539 [TBL] [Abstract][Full Text] [Related]
28. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544 [TBL] [Abstract][Full Text] [Related]
29. Epidemiology and Primary Prevention of Stroke. Furie K Continuum (Minneap Minn); 2020 Apr; 26(2):260-267. PubMed ID: 32224751 [TBL] [Abstract][Full Text] [Related]
30. The population approach to stroke prevention: a Canadian perspective. Young TK; Hachinski V Clin Invest Med; 2003 Apr; 26(2):78-86. PubMed ID: 12722841 [TBL] [Abstract][Full Text] [Related]
32. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Foreman KJ; Marquez N; Dolgert A; Fukutaki K; Fullman N; McGaughey M; Pletcher MA; Smith AE; Tang K; Yuan CW; Brown JC; Friedman J; He J; Heuton KR; Holmberg M; Patel DJ; Reidy P; Carter A; Cercy K; Chapin A; Douwes-Schultz D; Frank T; Goettsch F; Liu PY; Nandakumar V; Reitsma MB; Reuter V; Sadat N; Sorensen RJD; Srinivasan V; Updike RL; York H; Lopez AD; Lozano R; Lim SS; Mokdad AH; Vollset SE; Murray CJL Lancet; 2018 Nov; 392(10159):2052-2090. PubMed ID: 30340847 [TBL] [Abstract][Full Text] [Related]
33. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Raju N; Sobieraj-Teague M; Hirsh J; O'Donnell M; Eikelboom J Am J Med; 2011 Jul; 124(7):621-9. PubMed ID: 21592450 [TBL] [Abstract][Full Text] [Related]
34. Non-communicable disease prevention in Nepal: systemic challenges and future directions. Sharma SR; Page R; Matheson A; Lambrick D; Faulkner J; Mishra SR Glob Health Promot; 2019 Sep; 26(3):94-97. PubMed ID: 28862520 [TBL] [Abstract][Full Text] [Related]
35. Barriers to cardiovascular disease secondary prevention care in the West Bank, Palestine - a health professional perspective. Collier J; Kienzler H Confl Health; 2018; 12():27. PubMed ID: 30026794 [TBL] [Abstract][Full Text] [Related]
36. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. Carey KM; Comee MR; Donovan JL; Kanaan AO Ann Pharmacother; 2012 May; 46(5):688-95. PubMed ID: 22570437 [TBL] [Abstract][Full Text] [Related]
37. The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important? Khunti K; Gavin JR; Boulton AJM; Blickstead R; McGill M; Ceriello A; Raz I; Sadikot S; Wood DA; Cos X; Kalra S; Das AK; Espinosa López C; Prim Care Diabetes; 2018 Oct; 12(5):383-392. PubMed ID: 29752222 [TBL] [Abstract][Full Text] [Related]
38. World Stroke Organization global stroke services guidelines and action plan. Lindsay P; Furie KL; Davis SM; Donnan GA; Norrving B Int J Stroke; 2014 Oct; 9 Suppl A100():4-13. PubMed ID: 25250836 [TBL] [Abstract][Full Text] [Related]
39. Reducing the global burden of cardiovascular disease: the role of risk factors. Levenson JW; Skerrett PJ; Gaziano JM Prev Cardiol; 2002; 5(4):188-99. PubMed ID: 12417828 [TBL] [Abstract][Full Text] [Related]